Progressive Care included in Benzinga's latest announcement

October 16, 2019

Progressive Care Inc., a personalized health care services and technology company, announced the formation of its wholly owned subsidiary RXMD Therapeutics Inc., specializing in cannabinoid-based and alternative therapy product lines.The initial product line will consist of tinctures, skin creams, roll-ons and gel capsules. RXMD Therapeutics brands will be tested for consistency and quality assurance prior to release and periodically thereafter. The product line is expected to launch in early 2020. Learn more

Investors' Presentation